UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Perspective on the current state of the LRRK2 field

NPJ Parkinson's Disease, 2023-07, Vol.9 (1), p.104-104, Article 104

2023

Link zum Volltext

Verfügbarkeit prüfen

Doubly Constrained C‑terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) Dimerization

ACS chemical neuroscience, 2023-06, Vol.14 (11), p.1971-1980

2023

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal transcriptomic analysis of mouse sciatic nerve reveals pathways associated with age‐related muscle pathology

Journal of cachexia, sarcopenia and muscle, 2023-06, Vol.14 (3), p.1322-1336

2023

Link zum Volltext

Verfügbarkeit prüfen

Why the Gut Microbiome Must Be Considered When Evaluating the Impact of Pesticides on Parkinson’s Disease Risk

Journal of Parkinson's disease, 2023-01, Vol.13 (7), p.1077-1078

2023

Link zum Volltext

Verfügbarkeit prüfen

LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson’s disease

NPJ Parkinson's Disease, 2022-07, Vol.8 (1), p.92-92, Article 92

2022

Link zum Volltext

Verfügbarkeit prüfen

Distinct profiles of LRRK2 activation and Rab GTPase phosphorylation in clinical samples from different PD cohorts

NPJ Parkinson's Disease, 2022-06, Vol.8 (1), p.73-73, Article 73

2022

Link zum Volltext

Verfügbarkeit prüfen

Editorial: LRRK2-Fifteen Years From Cloning to the Clinic

Frontiers in neuroscience, 2022-04, Vol.16, p.880914-880914

2022

Link zum Volltext

Verfügbarkeit prüfen

Leucine rich repeat kinase 2 (LRRK2) peptide modulators: Recent advances and future directions

Peptide science (Hoboken, N.J.), 2022-01, Vol.114 (1), p.n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Allosteric Inhibition of Parkinson’s-Linked LRRK2 by Constrained Peptides

ACS chemical biology, 2021-11, Vol.16 (11), p.2326-2338

2021

Link zum Volltext

Verfügbarkeit prüfen

Defining (and blocking) neuronal death in Parkinson’s disease: Does it matter what we call it?

Brain research, 2021-11, Vol.1771, p.147639-147639, Article 147639

2021

Link zum Volltext

Verfügbarkeit prüfen

Elevated In Vitro Kinase Activity in Peripheral Blood Mononuclear Cells of Leucine‐Rich Repeat Kinase 2 G2019S Carriers: A Novel Enzyme‐Linked Immunosorbent Assay–Based Method

Movement disorders, 2020-11, Vol.35 (11), p.2095-2100

2020

Link zum Volltext

Verfügbarkeit prüfen

The Current State-of-the Art of LRRK2-Based Biomarker Assay Development in Parkinson’s Disease

Frontiers in neuroscience, 2020-08, Vol.14, p.865-865

2020

Link zum Volltext

Verfügbarkeit prüfen

The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson's Disease

Biomolecules (Basel, Switzerland), 2020-06, Vol.10 (6), p.912

2020

Link zum Volltext

Verfügbarkeit prüfen

The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson's Disease

Biomolecules (Basel, Switzerland), 2020-06, Vol.10 (6)

2020

Link zum Volltext

Verfügbarkeit prüfen

Vitamin B12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection

Cell research, 2019-04, Vol.29 (4), p.313-329

2019

Link zum Volltext

Verfügbarkeit prüfen

Vitamin B 12 modulates Parkinson's disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection

Cell research, 2019-04, Vol.29 (4), p.313

2019

Link zum Volltext

Verfügbarkeit prüfen

Kinase activity of mutant LRRK2 manifests differently in hetero-dimeric vs homo-dimeric complexes

Biochemical journal, 2019-02, Vol.476 (3), p.559-579

2019

Link zum Volltext

Verfügbarkeit prüfen

Insights into the Influence of Specific Splicing Events on the Structural Organization of LRRK2

International journal of molecular sciences, 2018-09, Vol.19 (9), p.2784

2018

Link zum Volltext

Verfügbarkeit prüfen

P62/SQSTM1 is a novel leucine-rich repeat kinase 2 (LRRK2) substrate that enhances neuronal toxicity

Biochemical journal, 2018-04, Vol.475 (7), p.1271-1293

2018

Link zum Volltext

Verfügbarkeit prüfen

A motif within the armadillo repeat of Parkinson's-linked LRRK2 interacts with FADD to hijack the extrinsic death pathway

Scientific reports, 2018-02, Vol.8 (1), p.3455-17, Article 3455

2018

Link zum Volltext

Verfügbarkeit prüfen

Nurr1:RXRa heterodimer activation as monotherapy for Parkinson's disease

Proceedings of the National Academy of Sciences - PNAS, 2017-04, Vol.114 (15), p.3999

2017

Link zum Volltext

Verfügbarkeit prüfen

Nurr1: RXRα heterodimer activation as monotherapy for Parkinson’s disease

Proceedings of the National Academy of Sciences - PNAS, 2017-04, Vol.114 (15), p.3999-4004

2017

Link zum Volltext

Verfügbarkeit prüfen

Neuronal death signaling pathways triggered by mutant LRRK2

Biochemical Society transactions, 2017-02, Vol.45 (1), p.123

Rideout, Hardy J

2017

Link zum Volltext

Verfügbarkeit prüfen

Leucine-Rich Repeat Kinase 2 (LRRK2)

1, 2017

Link zum Volltext

Verfügbarkeit prüfen

Part I: Clinical and Genetic Considerations of LRRK2 Associated Parkinson’s Disease

Leucine-Rich Repeat Kinase 2 (LRRK2), 2017, Vol.14

Rideout, Hardy J

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Englisch
(65)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Perspective on the current state of the LRRK2 field

Doubly Constrained C‑terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) Dimerization

Longitudinal transcriptomic analysis of mouse sciatic nerve reveals pathways associated with age‐related muscle pathology

Why the Gut Microbiome Must Be Considered When Evaluating the Impact of Pesticides on Parkinson’s Disease Risk

LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson’s disease

Distinct profiles of LRRK2 activation and Rab GTPase phosphorylation in clinical samples from different PD cohorts

Editorial: LRRK2-Fifteen Years From Cloning to the Clinic

Leucine rich repeat kinase 2 (LRRK2) peptide modulators: Recent advances and future directions

Allosteric Inhibition of Parkinson’s-Linked LRRK2 by Constrained Peptides

Defining (and blocking) neuronal death in Parkinson’s disease: Does it matter what we call it?

Elevated In Vitro Kinase Activity in Peripheral Blood Mononuclear Cells of Leucine‐Rich Repeat Kinase 2 G2019S Carriers: A Novel Enzyme‐Linked Immunosorbent Assay–Based Method

The Current State-of-the Art of LRRK2-Based Biomarker Assay Development in Parkinson’s Disease

The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson's Disease

The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson's Disease

Vitamin B12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection

Vitamin B 12 modulates Parkinson's disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection

Kinase activity of mutant LRRK2 manifests differently in hetero-dimeric vs homo-dimeric complexes

Insights into the Influence of Specific Splicing Events on the Structural Organization of LRRK2

P62/SQSTM1 is a novel leucine-rich repeat kinase 2 (LRRK2) substrate that enhances neuronal toxicity

A motif within the armadillo repeat of Parkinson's-linked LRRK2 interacts with FADD to hijack the extrinsic death pathway

Nurr1:RXRa heterodimer activation as monotherapy for Parkinson's disease

Nurr1: RXRα heterodimer activation as monotherapy for Parkinson’s disease

Neuronal death signaling pathways triggered by mutant LRRK2

Leucine-Rich Repeat Kinase 2 (LRRK2)

Part I: Clinical and Genetic Considerations of LRRK2 Associated Parkinson’s Disease

Suchergebnisse filtern